US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 43.170
  • -0.560-1.28%
Close Aug 2 16:00 ET
  • 43.170
  • 0.0000.00%
Post 18:12 ET
3.26BMarket Cap-15871P/E (TTM)

Xenon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
-48.83%9.43M
0
-98.38%132K
-75.83%536K
Operating revenue
--0
--0
--0
--0
--0
--0
-48.83%9.43M
--0
-98.38%132K
-75.83%536K
Cost of revenue
Gross profit
Operating expense
20.37%59.04M
54.47%214.05M
23.92%53.7M
45.54%55.68M
80.30%55.62M
87.68%49.05M
42.23%138.58M
51.64%43.33M
61.28%38.26M
24.82%30.85M
Selling and administrative expenses
55.12%14.79M
41.85%46.54M
48.44%12.62M
45.02%12.8M
33.07%11.58M
40.74%9.54M
49.36%32.81M
27.11%8.5M
82.76%8.83M
37.32%8.71M
-General and administrative expense
55.12%14.79M
41.85%46.54M
48.44%12.62M
45.02%12.8M
33.07%11.58M
40.74%9.54M
49.36%32.81M
27.11%8.5M
82.76%8.83M
37.32%8.71M
Research and development costs
11.98%44.25M
58.38%167.51M
17.93%41.08M
45.70%42.88M
98.86%44.04M
104.11%39.52M
40.16%105.77M
59.14%34.83M
55.79%29.43M
20.51%22.15M
Operating profit
-20.37%-59.04M
-65.75%-214.05M
-23.92%-53.7M
-46.04%-55.68M
-83.49%-55.62M
-182.41%-49.05M
-63.49%-129.14M
-74.45%-43.33M
-144.44%-38.13M
-34.75%-30.32M
Net non-operating interest income expense
109.39%11.36M
217.00%27.62M
94.73%8.69M
127.72%6.98M
699.51%6.52M
1,373.64%5.42M
1,769.74%8.71M
2,236.65%4.46M
5,278.95%3.07M
1,033.33%816K
Non-operating interest income
109.39%11.36M
217.00%27.62M
94.73%8.69M
127.72%6.98M
699.51%6.52M
1,373.64%5.42M
1,769.74%8.71M
2,236.65%4.46M
5,278.95%3.07M
1,033.33%816K
Other net income (expense)
-92.38%167K
177.70%3.75M
-97.86%56K
103.10%83K
183.52%1.42M
171.53%2.19M
-1,236.57%-4.83M
703.23%2.61M
-2,354.13%-2.68M
-1,799.00%-1.7M
Gain on sale of security
-92.38%167K
177.70%3.75M
-97.86%56K
103.10%83K
183.52%1.42M
171.53%2.19M
-1,236.57%-4.83M
703.23%2.61M
-2,354.13%-2.68M
-1,799.00%-1.7M
Income before tax
-14.68%-47.52M
-45.85%-182.69M
-23.97%-44.95M
-28.84%-48.62M
-52.83%-47.68M
-106.52%-41.44M
-58.78%-125.26M
-44.56%-36.26M
-141.13%-37.74M
-39.74%-31.2M
Income tax
42.07%412K
-347.46%-292K
-118.00%-205K
73.25%-157K
-450.00%-220K
173.60%290K
2,066.67%118K
135.33%1.14M
-186.34%-587K
81.57%-40K
Net income
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
-140.53%-37.15M
-40.93%-31.16M
Net income continuous Operations
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
-140.53%-37.15M
-40.93%-31.16M
Minority interest income
Net income attributable to the parent company
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
-140.53%-37.15M
-40.93%-31.16M
Preferred stock dividends
75.65%-437K
96.51%-17K
Other preferred stock dividends
Net income attributable to common stockholders
-14.87%-47.93M
-45.99%-182.39M
-19.70%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-115.41%-41.73M
-62.07%-124.94M
-49.05%-37.38M
-146.30%-37.15M
-44.33%-31.16M
Basic earnings per share
1.59%-0.62
-32.52%-2.73
-12.28%-0.64
-28.07%-0.73
-30.91%-0.72
-80.00%-0.63
-16.38%-2.06
-18.75%-0.57
-58.33%-0.57
-7.84%-0.55
Diluted earnings per share
1.59%-0.62
-32.52%-2.73
-12.28%-0.64
-28.07%-0.73
-30.91%-0.72
-80.00%-0.63
-16.38%-2.06
-18.75%-0.57
-58.33%-0.57
-7.84%-0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 000000-48.83%9.43M0-98.38%132K-75.83%536K
Operating revenue --0--0--0--0--0--0-48.83%9.43M--0-98.38%132K-75.83%536K
Cost of revenue
Gross profit
Operating expense 20.37%59.04M54.47%214.05M23.92%53.7M45.54%55.68M80.30%55.62M87.68%49.05M42.23%138.58M51.64%43.33M61.28%38.26M24.82%30.85M
Selling and administrative expenses 55.12%14.79M41.85%46.54M48.44%12.62M45.02%12.8M33.07%11.58M40.74%9.54M49.36%32.81M27.11%8.5M82.76%8.83M37.32%8.71M
-General and administrative expense 55.12%14.79M41.85%46.54M48.44%12.62M45.02%12.8M33.07%11.58M40.74%9.54M49.36%32.81M27.11%8.5M82.76%8.83M37.32%8.71M
Research and development costs 11.98%44.25M58.38%167.51M17.93%41.08M45.70%42.88M98.86%44.04M104.11%39.52M40.16%105.77M59.14%34.83M55.79%29.43M20.51%22.15M
Operating profit -20.37%-59.04M-65.75%-214.05M-23.92%-53.7M-46.04%-55.68M-83.49%-55.62M-182.41%-49.05M-63.49%-129.14M-74.45%-43.33M-144.44%-38.13M-34.75%-30.32M
Net non-operating interest income expense 109.39%11.36M217.00%27.62M94.73%8.69M127.72%6.98M699.51%6.52M1,373.64%5.42M1,769.74%8.71M2,236.65%4.46M5,278.95%3.07M1,033.33%816K
Non-operating interest income 109.39%11.36M217.00%27.62M94.73%8.69M127.72%6.98M699.51%6.52M1,373.64%5.42M1,769.74%8.71M2,236.65%4.46M5,278.95%3.07M1,033.33%816K
Other net income (expense) -92.38%167K177.70%3.75M-97.86%56K103.10%83K183.52%1.42M171.53%2.19M-1,236.57%-4.83M703.23%2.61M-2,354.13%-2.68M-1,799.00%-1.7M
Gain on sale of security -92.38%167K177.70%3.75M-97.86%56K103.10%83K183.52%1.42M171.53%2.19M-1,236.57%-4.83M703.23%2.61M-2,354.13%-2.68M-1,799.00%-1.7M
Income before tax -14.68%-47.52M-45.85%-182.69M-23.97%-44.95M-28.84%-48.62M-52.83%-47.68M-106.52%-41.44M-58.78%-125.26M-44.56%-36.26M-141.13%-37.74M-39.74%-31.2M
Income tax 42.07%412K-347.46%-292K-118.00%-205K73.25%-157K-450.00%-220K173.60%290K2,066.67%118K135.33%1.14M-186.34%-587K81.57%-40K
Net income -14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M-140.53%-37.15M-40.93%-31.16M
Net income continuous Operations -14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M-140.53%-37.15M-40.93%-31.16M
Minority interest income
Net income attributable to the parent company -14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M-140.53%-37.15M-40.93%-31.16M
Preferred stock dividends 75.65%-437K96.51%-17K
Other preferred stock dividends
Net income attributable to common stockholders -14.87%-47.93M-45.99%-182.39M-19.70%-44.74M-30.45%-48.46M-52.32%-47.46M-115.41%-41.73M-62.07%-124.94M-49.05%-37.38M-146.30%-37.15M-44.33%-31.16M
Basic earnings per share 1.59%-0.62-32.52%-2.73-12.28%-0.64-28.07%-0.73-30.91%-0.72-80.00%-0.63-16.38%-2.06-18.75%-0.57-58.33%-0.57-7.84%-0.55
Diluted earnings per share 1.59%-0.62-32.52%-2.73-12.28%-0.64-28.07%-0.73-30.91%-0.72-80.00%-0.63-16.38%-2.06-18.75%-0.57-58.33%-0.57-7.84%-0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg